JP2016536357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536357A5 JP2016536357A5 JP2016550931A JP2016550931A JP2016536357A5 JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5 JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- pancreatitis
- dimer
- domain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310549648.XA CN104623639A (zh) | 2013-11-07 | 2013-11-07 | 白介素22二聚体在制备治疗胰腺炎药物中的应用 |
| CN201310549648.X | 2013-11-07 | ||
| PCT/CN2014/090519 WO2015067198A1 (en) | 2013-11-07 | 2014-11-06 | Use of il-22 dimers in manufacture of medicaments for treating pancreatitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019129934A Division JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536357A JP2016536357A (ja) | 2016-11-24 |
| JP2016536357A5 true JP2016536357A5 (enExample) | 2017-12-14 |
| JP6825181B2 JP6825181B2 (ja) | 2021-02-03 |
Family
ID=53040916
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550931A Active JP6825181B2 (ja) | 2013-11-07 | 2014-11-06 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
| JP2019129934A Pending JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019129934A Pending JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160271221A1 (enExample) |
| EP (1) | EP3065765B1 (enExample) |
| JP (2) | JP6825181B2 (enExample) |
| CN (2) | CN104623639A (enExample) |
| AU (1) | AU2014346051B2 (enExample) |
| CA (1) | CA2929637C (enExample) |
| ES (1) | ES2794082T3 (enExample) |
| WO (1) | WO2015067198A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| CN106146668A (zh) * | 2015-04-01 | 2016-11-23 | 中国人民解放军第二军医大学 | 长效白细胞介素22的制备方法及其用途 |
| WO2016201007A1 (en) * | 2015-06-08 | 2016-12-15 | New York University | Stabilized minimal coiled-coil mimetics |
| EP3322719B1 (en) * | 2015-07-16 | 2019-12-18 | Philogen S.p.A. | Il22 immunoconjugates |
| WO2017181143A1 (en) | 2016-04-15 | 2017-10-19 | Generon (Shanghai) Corporation, Ltd. | Use of il-22 in treating necrotizing enterocolitis |
| AU2019337564A1 (en) | 2018-09-10 | 2021-05-06 | Cold Spring Harbor Laboratory | Methods for treating pancreatitis |
| CN110302363B (zh) * | 2019-07-04 | 2020-10-09 | 北京大学第三医院（北京大学第三临床医学院） | Il-22作为制备治疗pcos药物的应用及药物制剂 |
| EP4106794A4 (en) * | 2020-02-19 | 2024-03-20 | Evive Biotechnology (Shanghai) Ltd | METHOD FOR TREATING TRANSPLANT AND HOST DISEASE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503950A (ja) | 1992-12-02 | 1996-04-30 | アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド | 徐放性成長ホルモン含有マイクロスフェア |
| ES2151079T3 (es) | 1994-09-09 | 2000-12-16 | Takeda Chemical Industries Ltd | Preparacion de liberacion sostenida que contiene una sal metalica de un peptido. |
| WO1996040072A2 (en) | 1995-06-07 | 1996-12-19 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of human growth hormone |
| ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US6274710B1 (en) | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
| US7597876B2 (en) * | 2007-01-11 | 2009-10-06 | Immunomedics, Inc. | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
| CN100515491C (zh) * | 2005-01-04 | 2009-07-22 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| CN102380091A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗病毒性肝炎中的应用 |
| US8690554B2 (en) * | 2011-07-15 | 2014-04-08 | Xylem Ip Holdings Llc | Diaphragm pump using duckbill and other types of valves |
| EP2970422B1 (en) * | 2013-03-15 | 2018-04-18 | F.Hoffmann-La Roche Ag | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
-
2013
- 2013-11-07 CN CN201310549648.XA patent/CN104623639A/zh active Pending
-
2014
- 2014-11-06 ES ES14860161T patent/ES2794082T3/es active Active
- 2014-11-06 CA CA2929637A patent/CA2929637C/en active Active
- 2014-11-06 WO PCT/CN2014/090519 patent/WO2015067198A1/en not_active Ceased
- 2014-11-06 JP JP2016550931A patent/JP6825181B2/ja active Active
- 2014-11-06 US US15/034,857 patent/US20160271221A1/en not_active Abandoned
- 2014-11-06 AU AU2014346051A patent/AU2014346051B2/en active Active
- 2014-11-06 EP EP14860161.0A patent/EP3065765B1/en active Active
- 2014-11-06 CN CN201480061188.9A patent/CN105705160B/zh active Active
-
2019
- 2019-07-12 JP JP2019129934A patent/JP2019206548A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536357A5 (enExample) | ||
| JP2014530253A5 (enExample) | ||
| JP2016532690A5 (enExample) | ||
| JP2017528419A5 (enExample) | ||
| NZ598348A (en) | Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels | |
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| RU2014150224A (ru) | Сконструированный белок с анкириновым повтором, связывающийся с фактором роста тромбоцитов | |
| TW201613958A (en) | MIC-1 fusion proteins and uses thereof | |
| JP2015522576A5 (enExample) | ||
| PE20190920A1 (es) | Anticuerpos modificados de union a fcrn humano y metodos de utilizacion | |
| EA201290722A1 (ru) | Рекомбинантный белок эксендина-4 и его аналога, способ их приготовления и применение | |
| EA201201047A1 (ru) | Способы и композиции, в которых применяют слитые полипептиды fgf 23 | |
| PH12014501083A1 (en) | Anticancer fusion protein | |
| PH12018502451A1 (en) | Brain delivery protein | |
| JP2017531613A5 (enExample) | ||
| JP2014526881A5 (enExample) | ||
| JP2020507623A5 (enExample) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2018538356A5 (enExample) | ||
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| MY194925A (en) | Composition of fish skin collagen peptides and use thereof as a drug | |
| MX2021012047A (es) | Polipeptidos de fusion de serpina y metodos para utilizar los mismos. | |
| WO2016115511A3 (en) | Vegf variant polypeptide compositions | |
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2014519526A5 (enExample) |